PISTELLI, MIRCO
 Distribuzione geografica
Continente #
NA - Nord America 2.024
EU - Europa 738
AS - Asia 654
SA - Sud America 118
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 3
Totale 3.655
Nazione #
US - Stati Uniti d'America 1.974
SG - Singapore 214
IT - Italia 188
CN - Cina 137
VN - Vietnam 129
RU - Federazione Russa 110
BR - Brasile 90
SE - Svezia 77
IE - Irlanda 71
DE - Germania 66
UA - Ucraina 60
HK - Hong Kong 46
GB - Regno Unito 44
CI - Costa d'Avorio 43
FR - Francia 41
BD - Bangladesh 34
FI - Finlandia 26
TR - Turchia 24
CA - Canada 23
IN - India 21
DK - Danimarca 14
PL - Polonia 12
KR - Corea 11
AR - Argentina 10
JP - Giappone 10
MX - Messico 9
MA - Marocco 7
ZA - Sudafrica 7
CO - Colombia 5
ES - Italia 5
NL - Olanda 5
BE - Belgio 4
CL - Cile 4
IQ - Iraq 4
KE - Kenya 4
PK - Pakistan 4
AT - Austria 3
AU - Australia 3
CR - Costa Rica 3
EC - Ecuador 3
JO - Giordania 3
PR - Porto Rico 3
SV - El Salvador 3
AL - Albania 2
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
MD - Moldavia 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.605
Città #
Ashburn 345
Chandler 170
Singapore 130
Dallas 121
San Jose 115
Jacksonville 90
Fairfield 80
Dublin 70
New York 70
Boardman 56
Council Bluffs 56
Des Moines 55
Houston 44
Abidjan 43
Hong Kong 43
Beijing 40
Woodbridge 40
Ho Chi Minh City 39
Seattle 39
Wilmington 39
Los Angeles 34
Hanoi 32
The Dalles 30
Cambridge 27
Rome 24
Princeton 23
Lawrence 22
Munich 22
Ann Arbor 21
Moscow 20
San Mateo 20
Lauterbourg 17
Centro 15
Buffalo 13
Chicago 13
Santa Clara 13
São Paulo 13
Turku 13
London 12
San Diego 12
Milan 11
Orem 11
Phoenix 10
Turin 10
Warsaw 10
Washington 10
Irving 9
Montreal 9
Porto 8
Da Nang 7
Hefei 7
Stockholm 7
Tokyo 7
Boston 6
Brooklyn 6
Cagliari 6
Frankfurt am Main 6
Haiphong 6
Helsinki 6
Ancona 5
Cantu 5
Chennai 5
Chiaravalle 5
Denver 5
Falls Church 5
Guangzhou 5
Mexico City 5
Pune 5
Ankara 4
Brasília 4
Brussels 4
Johannesburg 4
Naples 4
New Delhi 4
Nonantola 4
Poplar 4
Prescot 4
Rio de Janeiro 4
Amman 3
Atlanta 3
Birmingham 3
Biên Hòa 3
Bắc Ninh 3
Calgary 3
Campinas 3
Columbus 3
Falconara Marittima 3
Hải Dương 3
Kilburn 3
Manchester 3
Miano 3
Mumbai 3
Nairobi 3
Newark 3
Salt Lake City 3
San Francisco 3
San Salvador 3
Shenzhen 3
Tampa 3
Thái Nguyên 3
Totale 2.384
Nome #
Role of DCE-MR in predicting breast cancer subtypes. 202
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 181
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 180
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 177
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 176
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 175
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 173
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 171
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study 159
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 155
Comparison Between Alendronate and Denosumab in Preventing Bone Loss and Lowering Fracture Risk Related to Adjuvant Endocrine Therapy for Breast Cancer: Real-World Data From a Third-Level Center Experience 148
A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study 147
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 144
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 144
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 144
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 143
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 141
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 141
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 138
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 132
Healthcare cost of HER2-positive and negative breast tumors in the United States (2012–2035) 131
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 129
Espressione di p-mTOR e del recettore degli androgeni nei tumori mammari triplo negativi: significato clinico e potenziali prospettive terapeutiche 119
Adjuvant Systemic Therapy in DCIS 105
Totale 3.655
Categoria #
all - tutte 16.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022140 0 0 0 1 2 29 11 9 17 22 17 32
2022/2023455 31 58 30 49 27 99 0 15 97 2 24 23
2023/2024242 46 3 16 17 33 70 4 16 0 3 0 34
2024/2025415 65 45 11 9 24 12 35 10 74 22 55 53
2025/20261.508 120 94 149 167 178 109 227 126 107 106 69 56
2026/2027262 37 41 45 139 0 0 0 0 0 0 0 0
Totale 3.655